Sorrento Therapeutics Inc (SRNE): It is interesting to compare the results...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Thursday, 10/28/2021 11:09:02 AM

Thursday, October 28, 2021 11:09:02 AM

It is interesting to compare the results of the Brazilian study of ABIVERTINIB to a Brazilian study of the highly touted drug chloroquine/hydroxychloroquine. While ABIVERTINIB proved to be about 55% more effective than SOC in status 5 patients the chloro/hydrochloro study was ended early "...DUE TO HARMFUL EFFECTS. Patients in the intervention group had a worse clinical outcome..."
See the study published April 27,2021
https://www.nature.com/articles/s41598-021-88509-9

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM